Envestnet Asset Management Inc Ab Cellera Biologics Inc. Transaction History
Envestnet Asset Management Inc
- $326 Billion
- Q2 2025
A detailed history of Envestnet Asset Management Inc transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 18,310 shares of ABCL stock, worth $106,930. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,310
Previous 21,960
16.62%
Holding current value
$106,930
Previous $48,000
29.17%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ABCL
# of Institutions
150Shares Held
114MCall Options Held
488KPut Options Held
476K-
Baker Bros. Advisors LP New York, NY27.5MShares$161 Million0.96% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$78 Million0.01% of portfolio
-
Baillie Gifford & CO10.4MShares$60.5 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL8.47MShares$49.5 Million0.01% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$26.6 Million0.02% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.67B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...